Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Haseebuddin

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
BJU International|May 31, 2019
Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal functionAndrew G McIntosh, Daniel C Parker, Brian L Egleston, et al.
Bladder Cancer (Amsterdam, Netherlands)|May 19, 2017
WBC Associates with Readmission Following CystectomyAndrew G McIntosh, Tianyu Li, Timothy Ito, et al.
World Journal of Urology|September 27, 2015
Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgeryRodrigo A Ledezma, Edris Negron, Gladell P Paner, et al.
Frontiers in Oncology|February 28, 2022
Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell CarcinomaJill W Ford, Marieli Gonzalez-Cotto, Alexander W MacFarlane, et al.
European Urology Oncology|November 14, 2018
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 TrialFern Anari, John O'Neill, Woonyoung Choi, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
BJU International|May 31, 2019
Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal functionAndrew G McIntosh, Daniel C Parker, Brian L Egleston, et al.
Bladder Cancer (Amsterdam, Netherlands)|May 19, 2017
WBC Associates with Readmission Following CystectomyAndrew G McIntosh, Tianyu Li, Timothy Ito, et al.
World Journal of Urology|September 27, 2015
Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgeryRodrigo A Ledezma, Edris Negron, Gladell P Paner, et al.
Frontiers in Oncology|February 28, 2022
Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell CarcinomaJill W Ford, Marieli Gonzalez-Cotto, Alexander W MacFarlane, et al.
European Urology Oncology|November 14, 2018
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 TrialFern Anari, John O'Neill, Woonyoung Choi, et al.
Pageof 2